Skip to main content
. 2020 Oct 26;232:105–115. doi: 10.1016/j.ahj.2020.10.065

Figure 4.

Figure 4

A, Geographic prevalence of COVID-19 cases as of August 7, 2020 (data from WHO COVID-19 Situation Report). B, Geographic prevalence of lead sponsors of trials of cardiovascular therapies related to COVID-19 registered on ClinicalTrials.gov as of August 7, 2020.